Haemonetics Corporation (HAE)

Quick ratio

		Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash	US$ in thousands	306,763	178,800	284,466	259,496	192,305
Short-term investments	US$ in thousands	—	1,673	1,110	—	—
Receivables	US$ in thousands	202,657	206,562	179,142	159,376	127,555
Total current liabilities	US$ in thousands	578,113	300,383	251,816	442,266	253,495
Quick ratio		0.88	1.29	1.85	0.95	1.26

March 31, 2025 calculation

Quick ratio = (Cash + Short-term investments + Receivables) ÷ Total current liabilities
= ($306,763K + $—K + $202,657K) ÷ $578,113K
= 0.88

The quick ratio, also known as the acid-test ratio, measures a company's ability to cover its short-term liabilities with its most liquid assets. For Haemonetics Corporation, the quick ratio has shown some fluctuations over the past five years.

As of March 31, 2021, the quick ratio was 1.26, indicating that the company had $1.26 in liquid assets available to cover each dollar of its current liabilities. This suggests a relatively healthy liquidity position at that time.

However, by March 31, 2022, the quick ratio decreased to 0.95, which may raise concerns as it fell below 1. This implies that the company's liquid assets might be insufficient to cover its short-term obligations.

The quick ratio improved significantly to 1.85 as of March 31, 2023, indicating a strong ability to meet current liabilities with liquid assets. This notable increase may reflect better liquidity management or improved cash reserves during that period.

By March 31, 2024, the quick ratio slightly declined to 1.29, which is still above the ideal threshold of 1. This demonstrates a relatively stable liquidity position for the company.

As of March 31, 2025, the data is unavailable (marked as "—"). Without this information, it is challenging to assess the company's current liquidity position and how it may have evolved in the most recent period.

In summary, although the quick ratio for Haemonetics Corporation has fluctuated over the years, it generally indicates the company's ability to meet its short-term obligations with liquid assets. Investors and analysts should continue to monitor the quick ratio to evaluate the company's liquidity health and management practices.